Global Next Generation Sequencing Market Size, Share, Forecast Report 2024

Global Next Generation Sequencing (NGS) market is expected to grow significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at a CAGR of 22.2% from 2018 to 2024. Factors propelling the growth of next generation sequencing (NGS) market include technological advancements in data integration and cloud computing, growing demand for new scientific research, and strong demand for clinical diagnostic. Moreover, increasing adoption of next generation sequencing technology in various end-user segments and growing investments in research and development is further propelling the market growth.

The years used for the assessment are as follows;

Historical year: 2014, 2015, and 2016

Base year: 2017

Forecast period: 2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, government websites, annual reports, press releases, white papers, surveys, investor presentation of companies, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total next generation sequencing market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global next generation sequencing market
  • Finalizing the overall size and share of the global next generation sequencing market

OBJECTIVES:

  • To analyze market trends, opportunities, drivers, and restraints associated with the global next generation sequencing market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the next generation sequencing market and provide their competitive landscape

MARKET SCOPE

The research scope for global next generation sequencing market is as follows:

By Product Type

  • Instruments
  • Reagents & consumables
  • Services

By Sequencing Type

  • Methyl Sequencing
  • Whole Genome Sequencing
  • CHIP Sequencing
  • Targeted Sequencing & Resequencing
    • RNA Based Targeted Sequencing
    • DNA Based Targeted Sequencing
  • De Novo Sequencing
  • Others

By Application

  • Diagnostics
    • Genetic Diagnostic
    • Pre-implantation Screening
    • Cancer Diagnostics
    • Prenatal Testing
    • Reproductive Health Diagnostics
    • Other
  • Drug Discovery
  • Personalized Medicine
  • Agriculture and Animal Research
  • Biomarker Discovery
  • Others

By End-User

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharmaceutical Companies
  • Biotech Companies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Next Generation Sequencing (NGS)- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global next generation sequencing (NGS) market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Technological advancements in data integration and cloud computing

3.5.2. Emerging applications of NGS in food testing and personalized medicine

3.5.3. Market driver analysis

    3.5.3.1. Strong demand for clinical diagnostic

    3.5.3.2. Increasing adoption of NGS technology in various end-user segments

    3.5.3.3. Increasing investments in research and development for genomic and proteomic sequence determination

    3.5.3.4. Increasing usage of NGS in drug development

3.5.4. Market restraint analysis

    3.5.4.1. Lack of skilled professionals

3.5.5. Industry Analysis-Porters five forces of analysis

CHAPTER 4. Competitive Outlook

4.1. Company share analysis

4.2. Competitive factors

4.3. Strategies adopted

CHAPTER 5. Global Next Generation Sequencing (NGS) Market Size and Forecast (2014 – 2024)

5.1. Global Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

5.1.1. Instruments

5.1.2. Reagents & consumables

5.1.3. Services

5.2. Global Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

5.2.1. Methyl Sequencing

5.2.2. Whole Genome Sequencing

5.2.3. CHIP Sequencing

5.2.4. Targeted Sequencing & Resequencing

    5.2.4.1. RNA Based Targeted Sequencing

    5.2.4.2. DNA Based Targeted Sequencing

5.2.5. De Novo Sequencing

5.2.6. Others

5.3. Global Next Generation Sequencing (NGS) Market, By Application (USD Billion)

5.3.1. Diagnostics

   5.3.1.1. Genetic Diagnostic

   5.3.1.2. Pre-implantation Screening

   5.3.1.3. Cancer Diagnostics

   5.3.1.4. Prenatal Testing

   5.3.1.5. Reproductive Health Diagnostics

   5.3.1.6. Other

5.3.2. Drug Discovery

5.3.3. Personalized Medicine

5.3.4. Agriculture and Animal Research

5.3.5. Biomarker Discovery

5.3.6. Others

5.4. Global Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

5.4.1. Academic Institutes & Research Centers

5.4.2. Hospitals & Clinics

5.4.3. Pharmaceutical Companies

5.4.4. Biotech Companies

CHAPTER 6. Global Next Generation Sequencing (NGS) Market, By Geography

6.1. North America Next Generation Sequencing (NGS) Market

6.1.1. North America Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.1.2. North America Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.1.3. North America Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.1.4. North America Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.1.5. North America Next Generation Sequencing (NGS) Market, By Country

   6.1.5.1. United States

   6.1.5.2. Canada

   6.1.5.3. Mexico

6.2. Europe Next Generation Sequencing (NGS) Market

6.2.1. Europe Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.2.2. Europe Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.2.3. Europe Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.2.4. Europe Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.2.5. Europe Next Generation Sequencing (NGS) Market, By Country

   6.2.5.1. United Kingdom

   6.2.5.2. France

   6.2.5.3. Germany

   6.2.5.4. Spain

   6.2.5.5. Netherlands

   6.2.5.6. Italy

   6.2.5.7. Belgium

   6.2.5.8. Sweden

   6.2.5.9. Switzerland

   6.2.5.10. Norway

   6.2.5.11. Austria

   6.2.5.12. Finland

   6.2.5.13. Denmark

   6.2.5.14. Iceland

   6.2.5.15. Portugal

   6.2.5.16. Russia

   6.2.5.17. Rest of Europe

6.3. Asia-Pacific Next Generation Sequencing (NGS) Market

6.3.1. Asia-Pacific Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.3.2. Asia-Pacific Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.3.3. Asia-Pacific Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.3.4. Asia-Pacific Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.3.5. Asia-Pacific Next Generation Sequencing (NGS) Market, By Country

    6.3.5.1. Japan

    6.3.5.2. China

    6.3.5.3. India

    6.3.5.4. Singapore

    6.3.5.5. Australia

    6.3.5.6. New Zealand

    6.3.5.7. Rest of Asia-Pacific

6.4. Central & South America Next Generation Sequencing (NGS) Market

6.4.1. Central & South America Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.4.2. Central & South America Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.4.3. Central & South America Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.4.4. Central & South America Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.4.5. Central & South America Next Generation Sequencing (NGS) Market, By Country

    6.4.5.1. Brazil

    6.4.5.2. Chile

    6.4.5.3. Argentina

    6.4.5.4. Rest of Central & South America

6.5. Middle East and Africa Next Generation Sequencing (NGS) Market

6.5.1. Middle East and Africa Next Generation Sequencing (NGS) Market, By Product Type (USD Billion)

6.5.2. Middle East and Africa Next Generation Sequencing (NGS) Market, By Sequencing Type (USD Billion)

6.5.3. Middle East and Africa Next Generation Sequencing (NGS) Market, By Application (USD Billion)

6.5.4. Middle East and Africa Next Generation Sequencing (NGS) Market, By End-User (USD Billion)

6.5.5. Middle East and Africa Next Generation Sequencing (NGS) Market, By Region

    6.5.5.1. Saudi Arabia

    6.5.5.2. United Arab Emirates

    6.5.5.3. Qatar

    6.5.5.4. South Africa

    6.5.5.5. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Illumina, Inc.

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Oxford Nanopore Technologies

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Pacific Biosciences of California, Inc

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. Agilent Technologies, Inc.

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. GENEWIZ, Inc.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. PierianDx.

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Eurofins Genomics

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. 10x Genomics

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Genomatix AG

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. QIAGEN

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. BGI Genomics Co., Ltd.

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

7.12. Macrogen, Inc

7.12.1. Business Overview

7.12.2. Product and Service Offering

7.12.3. Financial Overview

7.12.4. Strategic Developments

7.13. Thermo Fisher Scientific

7.13.1. Business Overview

7.13.2. Product and Service Offering

7.13.3. Financial Overview

7.13.4. Strategic Developments